Application of chimeric antigen receptor-T cell therapy in hematological diseases: reports from the 57th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2016.01.002
- VernacularTitle:嵌合抗原受体T细胞疗法在血液病中的应用:第57届美国血液学会年会报道
- Author:
Yixin ZOU
;
Yi MIAO
;
Wei XU
;
Jianyong LI
- Publication Type:Journal Article
- Keywords:
Chimeric antigen receptor T-cell;
Immunotherapy;
Hematologic neoplasms;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2016;25(1):4-6
- CountryChina
- Language:Chinese
-
Abstract:
Chimeric antigen receptor-T cell (CAR-T) therapy is one of the effective novel immunotherapy for malignancies, and it has a great effect on leukemia and lymphoma. More researches are needed to improve the understanding of CAR-T therapy and promote the development of this technology in order to treat hematological malignancies from a novel perspective.
